|
|||||
|
|
2-chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients |
|
| Authors: | Kimo C. Stine Robert L. Saylors Laura L. Williams David L. Becton |
| Abstract: | |
| Keywords: | Langerhans cell histiocytosis (LCH) 2-chlorodeoxyadenosine (2-CDA) pediatrics |